The JAK/STAT pathway: a pivotal therapeutic target in disease and advances in natural product modulation.

Li MY, Lin YY, Wang CY, Qi YS, Zhang JS, Ge D, Yu HN, Zhang H, Bao J

Open source

DOI
10.1007/s11030-026-11679-z
Published
2026 Aug 12
Container
Molecular diversity
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11030-026-11679-z,
  title = {The JAK/STAT pathway: a pivotal therapeutic target in disease and advances in natural product modulation.},
  author = {Li MY and Lin YY and Wang CY and Qi YS and Zhang JS and Ge D and Yu HN and Zhang H and Bao J},
  year = {2026},
  journal = {Molecular diversity},
  doi = {10.1007/s11030-026-11679-z},
  url = {https://doi.org/10.1007/s11030-026-11679-z}
}

RIS

TY  - JOUR
TI  - The JAK/STAT pathway: a pivotal therapeutic target in disease and advances in natural product modulation.
AU  - Li MY
AU  - Lin YY
AU  - Wang CY
AU  - Qi YS
AU  - Zhang JS
AU  - Ge D
AU  - Yu HN
AU  - Zhang H
AU  - Bao J
PY  - 2026
JO  - Molecular diversity
DO  - 10.1007/s11030-026-11679-z
UR  - https://doi.org/10.1007/s11030-026-11679-z
ER  - 

APA

MY, L., YY, L., CY, W., YS, Q., JS, Z., D, G., HN, Y., H, Z., & J, B. (2026). The JAK/STAT pathway: a pivotal therapeutic target in disease and advances in natural product modulation.. Molecular diversity. https://doi.org/10.1007/s11030-026-11679-z

Source records